Weinberg, B. A., Lekan, A., Malchiodi, Z., Fitzgerald, A., Tan, M. T., Geng, X., Noel, M. S., He, A. R., Mukherji, R., Marshall, J. L., Gutierrez, M., Jones, P., Deshpande, R. M., Weiner, L. M. (2026). BXCL701 plus pembrolizumab in second-line advanced pancreatic ductal adenocarcinoma: Final outcomes of the EXPEL PANC trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4201